Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tommi Tervonen

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Clinical Pharmacology and Therapeutics|April 1, 2019
Quantifying Preferences in Drug Benefit-Risk DecisionsTommi Tervonen, Aris Angelis, Kimberley Hockley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 16, 2023
Two Methods, One Story? Comparing Results of a Choice Experiment and Multidimensional Thresholding From a Clinician Preference Study in Aneurysmal Subarachnoid HemorrhageSebastian Heidenreich, Myrto Trapali, Nicolas Krucien, et al.
Journal of Clinical Epidemiology|December 2, 2021
Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessmentTommi Tervonen, Thibaud Prawitz, Gin Nie Chua, et al.
Statistics in Medicine|January 27, 2011
A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysisTommi Tervonen, Gert van Valkenhoef, Erik Buskens, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 12, 2013
A multi-criteria decision analysis perspective on the health economic evaluation of medical interventionsDouwe Postmus, Tommi Tervonen, Gert van Valkenhoef, et al.
Neurology and Therapy|February 27, 2023
Discrete Choice Experiment to Understand Japanese Patients' and Physicians' Preferences for Preventive Treatments for MigraineJaein Seo, Tommi Tervonen, Kaname Ueda, et al.
The Patient|December 14, 2020
Willingness to Wait for a Vaccine Against COVID-19: Results of a Preference SurveyTommi Tervonen, Aura Cecilia Jimenez-Moreno, Nicolas Krucien, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 9, 2019
Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice ExperimentAnne Brooks, Jakob Langer, Tommi Tervonen, et al.
Thorax|July 8, 2020
Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experimentTommi Tervonen, Natalia Hawken, Nicola A Hanania, et al.
BMJ Open|August 2, 2022
Patient preferences for atopic dermatitis medications in the UK, France and Spain: a discrete choice experimentCaitlin Thomas, Afaf Raibouaa, Andreas Wollenberg, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Clinical Pharmacology and Therapeutics|April 1, 2019
Quantifying Preferences in Drug Benefit-Risk DecisionsTommi Tervonen, Aris Angelis, Kimberley Hockley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 16, 2023
Two Methods, One Story? Comparing Results of a Choice Experiment and Multidimensional Thresholding From a Clinician Preference Study in Aneurysmal Subarachnoid HemorrhageSebastian Heidenreich, Myrto Trapali, Nicolas Krucien, et al.
Journal of Clinical Epidemiology|December 2, 2021
Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessmentTommi Tervonen, Thibaud Prawitz, Gin Nie Chua, et al.
Statistics in Medicine|January 27, 2011
A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysisTommi Tervonen, Gert van Valkenhoef, Erik Buskens, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 12, 2013
A multi-criteria decision analysis perspective on the health economic evaluation of medical interventionsDouwe Postmus, Tommi Tervonen, Gert van Valkenhoef, et al.
Neurology and Therapy|February 27, 2023
Discrete Choice Experiment to Understand Japanese Patients' and Physicians' Preferences for Preventive Treatments for MigraineJaein Seo, Tommi Tervonen, Kaname Ueda, et al.
The Patient|December 14, 2020
Willingness to Wait for a Vaccine Against COVID-19: Results of a Preference SurveyTommi Tervonen, Aura Cecilia Jimenez-Moreno, Nicolas Krucien, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 9, 2019
Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice ExperimentAnne Brooks, Jakob Langer, Tommi Tervonen, et al.
Thorax|July 8, 2020
Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experimentTommi Tervonen, Natalia Hawken, Nicola A Hanania, et al.
BMJ Open|August 2, 2022
Patient preferences for atopic dermatitis medications in the UK, France and Spain: a discrete choice experimentCaitlin Thomas, Afaf Raibouaa, Andreas Wollenberg, et al.
Pageof 6